What is it about?
In advanced cancer patients, pain may be difficult to treat. Intrathecal drugs administration is a very diffused option. In this study, three different medicines were combined, for an optimal results.
Featured Image
Photo by National Cancer Institute on Unsplash
Why is it important?
This research has shown the importance of a tailored therapy with combination of different analgesics, when terminal cancer patients have a difficult pain to be treated.
Perspectives
The study is opening a research path on the treatment of cancer pain patients. More studies would be necessary to explore new combinations, and/or diffeent dosages of the same drugs.
Professor Giustino Varrassi
Fondazione Paolo Procacci
Read the Original
This page is a summary of: Triple Intrathecal Combination Therapy for End-Stage Cancer-Related Refractory Pain: A Prospective Observational Study with Two-Month Follow-Up, Pain and Therapy, April 2020, Springer Science + Business Media,
DOI: 10.1007/s40122-020-00169-1.
You can read the full text:
Contributors
The following have contributed to this page
